Compared with those in the non-bone metastasis group, the serum levels of all BME cytokines in the bone metastasis group were significantly elevated, including CaN, OPG, PTHrP, and IL-6 (P < 0.05) (Fig. 1 A/B/C/D). This evidence concerns the gene IL6 and bone metastasis.